Dow Up 1.63% Nasdaq Up 0.97%

Athersys, Inc. (ATHX)

-NasdaqCM
1.32 Oct 17, 4:00PM EDT
Prev Close:1.32
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:6.25
Beta:-0.26
Next Earnings Date:10-Nov-14ATHX Earnings announcement
Day's Range:N/A - N/A
52wk Range:1.08 - 4.33
Volume:0
Avg Vol (3m):300,009
Market Cap:102.01M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which has Phase I... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback